Neue orale Antikoagulanzien und Endoskopie - was ist zu beachten?

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Sven Pannach - , Department of internal Medicine I, University Hospital Carl Gustav Carus Dresden (Author)
  • Jan Beyer-Westendorf - , University Vascular Centre, University Hospital Carl Gustav Carus Dresden (Author)

Abstract

Anti-coagulated patients often undergo endoscopic procedures and non-vitamin-K-antagonist oral anticoagulants (NOAC) are increasingly prescribed. Consequently, a comprehensive knowledge about the adequate peri-interventional handling of these substances is required. A standardized approach needs to be planned for elective and emergency situations. As a result of their pharmacokinetics, the peri-endoscopic management of NOAC is relatively easy - an heparin bridging/switching is usually not required. In case of a severe NOAC bleeding endoscopic treatment must be considered at an early stage.

Translated title of the contribution
New oral anticoagulants and endoscopy - What do you have to consider?

Details

Original languageGerman
Pages (from-to)1227-1230
Number of pages4
JournalDeutsche Medizinische Wochenschrift
Volume140
Issue number16
Publication statusPublished - 13 Aug 2015
Peer-reviewedYes

External IDs

PubMed 26261933

Keywords

ASJC Scopus subject areas

Keywords

  • NOAC, peri-endoscopic management